| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |